Drug FDA Class II Ongoing Foreign material
Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04
Pfizer Inc. Published Aug 6, 2025
Risk level
Class IIMay cause a temporary or reversible health problem; slight chance of serious harm.
Severity score 60/100
What should you do?
- Check whether you have this product, using the lot codes, UPCs, and dates listed below.
- Do not eat, serve, or sell the affected product.
- Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
- Contact Pfizer Inc. or your place of purchase with questions, and see the source record below for full details.
Reason for recall
CGMP Deviations; particulates identified during visual inspection
Hazards
Particulate Matter · primary
Affected products (1)
Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04
BICILLIN L-A · 19,279 vials
NDC: 60793-700, 60793-701, 60793-702, 60793-700-01, 60793-700-10, 60793-701-02, 60793-701-10, 60793-702-04, 60793-702-10
Lot codes: GT2598
Code info: Lots GT2598, GT2599, Exp 09/30/26; HK2909, Exp 02/28/27; HR9969, Exp 04/30/27; HR9984, Exp 08/31/27.
Affected areas
Nationwide
Timeline
- InitiatedJul 10, 2025
- PublishedAug 6, 2025
- Recall number
- D-0545-2025
- Agency
- U.S. Food and Drug Administration
- Country
- US
FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.